NCT06777173View on ClinicalTrials.gov

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

NAEnrolling by invitationINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions

Chronic Hepatitis bImmunotherapy

Interventions

DRUG

Peg interferon alfa-2b

NA combined with Peg interferon alfa-2b

Trial Locations (1)

Unknown

Beijing Ditan hospital, Beijing

All Listed Sponsors

lead

Beijing Ditan Hospital

OTHER